A Phase I, Double Blind, Randomized, Placebo Controlled, Maximal Dose Study to Determine the Safety, Tolerability of Topical Cream Containing MGC (Medical Grade Cannabis) in Healthy Volunteers
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 02 Dec 2016
At a glance
- Drugs Marijuana (Primary)
- Indications Psoriasis
- Focus Adverse reactions
- Sponsors One World Cannabis
- 11 Oct 2016 According to an OWC Pharmaceuticals Research Corp media release, this trial will start upon receiving the Institutional Review Board (IRB) approval by the national IRB committee which is expected to be assembled in November 2016.
- 11 Mar 2016 New trial record
- 09 Mar 2016 According to OWC Pharmaceuticals media release, company has finished the IRB (Institutional Review Board) protocol for this trial.